Related Experiment Video
Updated: Jun 21, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
p300 KAT Regulates SOX10 Stability and Function in Human Melanoma
Aaron Waddell1, Nicole Grbic1, Kassidy Leibowitz1
1Department of Dermatology, Boston University Aram V. Chobanian and Edward Avedisian School of Medicine, Boston, Massachusetts.
Targeting the SOX10/p300 axis with A-485 inhibits melanoma growth and invasion. This p300 inhibitor reduces SOX10 protein levels, offering a potential therapy for SOX10-reliant melanoma tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- SOX10 is crucial for melanoma growth but its loss promotes invasion and therapy resistance.
- Targeting SOX10 for proliferation inhibition risks increasing melanoma cell invasion.
- Co-amplification of EP300 and SOX10 genes occurs in various melanoma types.
Purpose of the Study:
- To investigate the SOX10/p300 interaction in melanoma.
- To evaluate the therapeutic potential of p300 inhibition in melanoma.
Main Methods:
- Analysis of EP300 and SOX10 gene co-amplification in melanoma samples.
- Assessing the effect of p300 inhibitor A-485 on SOX10 protein stability and degradation.
- Evaluating A-485's impact on melanoma cell proliferation and invasion in vitro.
Main Results:
- p300 lysine acetyltransferase (KAT) activity stabilizes SOX10 protein.
- A-485 treatment downregulates SOX10 via proteasomal degradation.
- A-485 inhibits proliferation of SOX10+ melanoma cells and reduces invasion in AXLhigh/MITFlow cells.
Conclusions:
- The SOX10/p300 axis is vital for melanoma growth and invasion.
- Inhibiting p300 KAT activity with A-485 is a promising therapeutic strategy for SOX10-dependent melanomas.
Related Concept Videos
Pleiotropy
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Master Transcription Regulators

